E1.Initial reporter phone: (b)(6).The hardware investigation has begun but it has not been completed at this time.When the investigational analysis has been completed, a supplemental 3500a report will be submitted.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster, inc., or its employees that the report constitutes an admission that the product, biosense webster, inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
|
It was reported that a patient underwent an atrial fibrillation (afib) procedure with a carto® 3 system and a map shift with no error message/warning/alert, no cardioversion performed and no patient movement issue occurred.Initially it was reported that they had a map shift without any warning or alert.It was verified by intracardiac echocardiography (ice) that there was a map shift and they had to make a new map.There was no patient consequence reported.Additional information was received on 12-feb-2024.No error seen.Map shift was confirmed using ice.Issue seen during ablation.Approximate distance was more than 1 cm.No cardioversion or patient movement before the shift.This map shift with no error/warning/alert event was originally considered non-reportable, however, bwi became aware that there was no cardioversion or patient movement before the shift on 12-feb-2024 and have reassessed the event as reportable.
|